Pulse cyclophosphamide therapy for inflammatory bowel disease

World Journal of Gastroenterology

Volumn 12, Issue 8, 2006, Pages 1278-1280

  Barta, Zsolt ^a   Tóth, László ^a   Zeher, Margit ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Crohn's disease; Cyclophosphamide; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; BUDESONIDE; CYCLOPHOSPHAMIDE; METHOTREXATE; STEROID;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; COLONOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG EFFICACY; DRUG PULSE THERAPY; DRUG RESPONSE; DRUG TOLERABILITY; ENTERITIS; FEMALE; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; REMISSION; ULCERATIVE COLITIS;

EID: 33645533060     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i8.1278     Document Type: Article

References (10)

1. Arnott ID, McDonald D, Williams A, Ghosh S. Clinical use of Infliximab in Crohn's disease: the Edinburgh experience. Aliment Pharmacol Ther 2001; 15: 1639-1646
2. Riley P, Maillard SM, Wedderburn LR, Woo P, Murray KJ, Pilkington CA. Intravenous cyclophosphamide pulse therapy in juvenile dermatomyositis. A review of efficacy and safety. Rheumatology (Oxford) 2004; 43: 491-496
3. McCune WJ, Golbus J, Zeldes W, Bohlke P, Dunne R, Fox DA. Clinical and immunologic effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus. N Engl J Med 1988; 318: 1423-1431
4. Watts RA, Scott DG, Pusey CD, Lockwood CM. Vasculitis-aims of therapy. An overview. Rheumatology (Oxford) 2000; 39: 229-232
5. Stallmach A, Wittig BM, Moser C, Fischinger J, Duchmann R, Zeitz M. Safety and efficacy of intravenous pulse cyclophosphamide in acute steroid refractory inflammatory bowel disease. Gut 2003; 52: 377-382
6. Sands BE, Tremaine WJ, Sandborn WJ, Rutgeerts PJ, Hanauer SB, Mayer L, Targan SR, Podolsky DK. Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study. Inflamm Bowel Dis 2001; 7: 83-88
7. Drossman DA, Li Z, Leserman J, Patrick DL. Ulcerative colitis and Crohn's disease health status scales for research and clinical practice. J Clin Gastroenterol 1992; 15: 104-112
8. Daperno M, Sostegni R, Scaglione N, Ercole E, Rigazio C, Rocca R, Pera A. Outcome of a conservative approach in severe ulcerative colitis. Dig Liver Dis 2004; 36: 21-28
9. Kane SV, Schoenfeld P, Sandborn WJ, Tremaine W, Hofer T, Feagan BG. The effectiveness of budesonide therapy for Crohn's disease. Aliment Pharmacol Ther 2002; 16: 1509-1517
10. Shimada T, Hiwatashi N, Yamazaki H, Kinouchi Y, Toyota T. Relationship between glucocorticoid receptor and response to glucocorticoid therapy in ulcerative colitis. Dis Colon Rectum 1997; 40: S54-58